ESC 365 - Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

ESC Premium Access

Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

Session: Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Mr S. Marelli (Pavia, IT)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Mr Stefano Marelli

ICS Maugeri - IRCCS Pavia, Pavia (Italy)

0 follower

7 more presentations in this session

Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator

Speaker: Doctor V. Waldmann (Paris, FR)

Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response

Speaker: Mr M. Ghossein (Maastricht, NL)

Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study

Speaker: Miss A. Alhakak (Copenhagen, DK)

Relationship between mortality after ICD implantation and center volume in Belgium

Speaker: Mr R. Hoffmann (Leuven, BE)

Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study

Speaker: Miss A. Alhakak (Copenhagen, DK)

Access the full session

Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

Speakers: Mr S. Marelli, Doctor V. Waldmann, Mr M. Ghossein, Miss A. Alhakak, Mr R. Hoffmann...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources